C1q: A fresh look upon an old molecule.
N. Thielens+4 more
semanticscholar +1 more source
Correction to "Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain-Barré Syndrome". [PDF]
europepmc +1 more source
Role of adiponectin and its receptors AdipoR1/2 in inflammatory bowel disease. [PDF]
Zhu Q, Jia X, Li S, Feng J.
europepmc +1 more source
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies. [PDF]
Brennan FR+29 more
europepmc +1 more source
Dynamic Alterations in DNA Methylation of CD4<sup>+</sup> T Cells and Macrophages in a Murine Model of Tuberculous Pleural Infection Induced by BCG Vaccination. [PDF]
Shao MM+6 more
europepmc +1 more source
Evolving understanding of Guillain-Barré syndrome pathophysiology and the central role of the classical complement pathway in axonal injury. [PDF]
Gorson KC.
europepmc +1 more source
Role of local complement activation in kidney fibrosis and repair. [PDF]
Portilla D, Sabapathy V, Chauss D.
europepmc +1 more source